SIGNATURE,NAME,DESCRIPTION,URL
DBS1,DBS1 (UV),Exposure to ultraviolet light; associated with SBS7a/SBS7b and also with ID13 which predominantly generates single base thymine deletions at TT dinucleotides,https://cancer.sanger.ac.uk/signatures/dbs/dbs1
DBS2,DBS2 (Smoking),"Exposure to tobacco smoking as well as other endogenous and/or exogenous mutagens (e.g., acetaldehyde); in addition to its presence in tobacco smoking induced cancers, DBS2 is also found in many cancer types unrelated to tobacco smoking; associated with SBS4 and ID3",https://cancer.sanger.ac.uk/signatures/dbs/dbs2
DBS3,DBS3 (POLE),Polymerase epsilon exonuclease domain mutations; associated with SBS10a/SBS10b,https://cancer.sanger.ac.uk/signatures/dbs/dbs3
DBS4,DBS4 (Unknown),Unknown etiology; its mutation burden correlates with the age of cancer diagnosis and this clock-like feature suggests that it is generated in normal human cells,https://cancer.sanger.ac.uk/signatures/dbs/dbs4
DBS5,DBS5 (Platinum),Prior chemotherapy treatment with platinum drugs; associated with SBS31 and SBS35,https://cancer.sanger.ac.uk/signatures/dbs/dbs5
DBS6,DBS6 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/dbs/dbs6
DBS7,DBS7 (MMR),"Defective DNA mismatch repair (MMR); associated with large numbers of ID1 and ID2 mutations and in certain cancers with single base substitution signatures associated with defective DNA mismatch repair including SBS6, SBS14, SBS15, SBS20, SBS21, SBS26 and SBS44",https://cancer.sanger.ac.uk/signatures/dbs/dbs7
DBS8,DBS8 (Unknown),"Unknown; found in rare hypermutated cancers with large numbers of single base substitutions similar to SBS1 and SBS5, but not apparently DNA mismatch repair defective or polymerase epsilon mutated; associated with SBS89",https://cancer.sanger.ac.uk/signatures/dbs/dbs8
DBS9,DBS9 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/dbs/dbs9
DBS10,DBS10 (MMR),"Defective DNA mismatch repair (MMR); associated with some of the single base substitution mutational signatures present in DNA mismatch repair deficient cancers SBS6, SBS14, SBS15, SBS20, SBS21, SBS26, and SBS44, and with large numbers of ID1 and ID2 mutations",https://cancer.sanger.ac.uk/signatures/dbs/dbs10
DBS11,DBS11 (Unknown),"Unknown, possibly related to APOBEC mutagenesis; found in samples with large numbers of SBS2 and SBS13 mutations",https://cancer.sanger.ac.uk/signatures/dbs/dbs11
ID1,ID1 (Slippage),"Slippage during DNA replication of the replicated DNA strand; tends to be highly elevated in cancer samples with defective DNA mismatch repair and microsatellite instability (MSI); associated with SBS6, SBS14, SBS15, SBS20, SBS21, SBS26, and/or SBS44 and with SBS1 in non-hypermutated samples",https://cancer.sanger.ac.uk/signatures/id/id1
ID2,ID2 (Slippage),"Slippage during DNA replication of the template DNA strand; tends to be highly elevated in cancer samples with defective DNA mismatch repair and microsatellite instability (MSI); associated with SBS6, SBS14, SBS15, SBS20, SBS21, SBS26, and/or SBS44 and with SBS1 in non-hypermutated samples",https://cancer.sanger.ac.uk/signatures/id/id2
ID3,ID3 (Smoking),Associated with tobacco smoking; associated with SBS4 and DBS2,https://cancer.sanger.ac.uk/signatures/id/id3
ID4,ID4 (Unknown),Unknown; shows large numbers of mutations in a subset of samples which do not obviously have the mutational features of defective DNA mismatch repair,https://cancer.sanger.ac.uk/signatures/id/id4
ID5,ID5 (Unknown),Unknown; the mutation burden is correlated with the age of cancer diagnosis and this clock-like behaviour suggests that ID5 mutations may accumulate in normal cells; associated with SBS40,https://cancer.sanger.ac.uk/signatures/id/id5
ID6,ID6 (HRD),"homologous recombination-based DNA damage repair defects (HRD), often due to inactivating BRCA1 or BRCA2 mutations, leading to non-homologous DNA end-joining activity; associated with SBS3",https://cancer.sanger.ac.uk/signatures/id/id6
ID7,ID7 (MMR),Defective DNA mismatch repair; associated with ID1 and ID2 mutations,https://cancer.sanger.ac.uk/signatures/id/id7
ID8,ID8 (Unknown),Appears to be caused by at least two underlying mechanisms: the features of ID8 mutations have some similarities to those of radiation induced mutations and the small number of tumors with the somatic p.K743N mutation have a form of ID8 that shows evidence of transcription-associated damage,https://cancer.sanger.ac.uk/signatures/id/id8
ID9,ID9 (Unknown),Unknown,https://cancer.sanger.ac.uk/signatures/id/id9
ID10,ID10 (Unknown),Unknown,https://cancer.sanger.ac.uk/signatures/id/id10
ID11,ID11 (Unknown),Unknown; occasional samples show large numbers of ID11 mutations without obvious evidence of defective DNA mismatch repair,https://cancer.sanger.ac.uk/signatures/id/id11
ID12,ID12 (Unknown),Unknown,https://cancer.sanger.ac.uk/signatures/id/id12
ID13,ID13 (UV),"Found in cancers of the skin from sun exposed areas, therefore, this signature is likely to be due to exposure to ultraviolet light; associated with DBS1, SBS7a and SBS7b",https://cancer.sanger.ac.uk/signatures/id/id13
ID14,ID14 (Unknown),Unknown; generates large numbers of indels in a small number of samples without obvious evidence of defective DNA mismatch repair,https://cancer.sanger.ac.uk/signatures/id/id14
ID15,ID15 (Unknown),Unknown; generates a large number of indels in a small number of cancers without obvious evidence of defective DNA mismatch repair,https://cancer.sanger.ac.uk/signatures/id/id15
ID16,ID16 (Unknown),Unknown; generates high number of indels in a single ovarian cancer without obvious evidence of defective DNA mismatch repair,https://cancer.sanger.ac.uk/signatures/id/id16
ID17,ID17 (TOP2A),Appears to be caused by mutations in topoisomerase TOP2A; ID17 generates a large number of indels in a small number of cancers without obvious evidence of defective DNA mismatch repair,https://cancer.sanger.ac.uk/signatures/id/id17
ID18,ID18 (Colibactin),"Exposure to E.coli bacteria carrying pks pathogenicity island, producing genotoxic compound colibactin; associated with SBS88",https://cancer.sanger.ac.uk/signatures/id/id18
SBS1,SBS1 (Age),Number of mutations correlated with age; associated with endogenous process initiated by deamination of 5-methylcytosine to thymine generating T>C substitutions; closely correlated with SBS5 in many tumor types,https://cancer.sanger.ac.uk/signatures/sbs/sbs1
SBS2,SBS2 (APOBEC),Attributed to activity of AID/APOBEC family of cytidine deaminases; commonly found in some cancers with local hypermutation (kataegis); associated with SBS13 and DBS 11,https://cancer.sanger.ac.uk/signatures/sbs/sbs2
SBS3,SBS3 (HRD),"Attributed to homologous recombination defects (HRD) in DNA damage response, most often found with germline and somatic BRCA mutations in breast, pancreatic, ovarian cancers, and in pancreatic tumors responsive to platinum therapy; associated with ID6",https://cancer.sanger.ac.uk/signatures/sbs/sbs3
SBS4,SBS4 (Smoking),Associated with tobacco smoking likely due to direct DNA damage by tobacco smoke mutagens; frequently found in lung and head & neck cancers; associated with DSB2,https://cancer.sanger.ac.uk/signatures/sbs/sbs4
SBS5,SBS5 (Unknown),Unknown etiology but is clock-like with the number of mutations in most cancers and normal cells correlated with the age,https://cancer.sanger.ac.uk/signatures/sbs/sbs5
SBS6,SBS6 (MMR/MSI),"Associated with defective DNA mismatch repair (MMR) and is found in microsatellite unstable (MSI) tumors; one of 7 signatures associated with MMR/MSI along with SBS14, SBS15, SBS20, SBS21, SBS26, and SBS44; also associated with large numbers of ID1 and ID2 ",https://cancer.sanger.ac.uk/signatures/sbs/sbs6
SBS7a,SBS7a (UV),"Attributed to ultraviolet light (UV) exposure and found in cancers of the skin; one of 4 signatures associated with UV exposure (SBS7b, SBS7c, and SBS7d); also associated with DSB1 and ID13",https://cancer.sanger.ac.uk/signatures/sbs/sbs7a
SBS7b,SBS7b (UV),"Attributed to ultraviolet light (UV) exposure and found in cancers of the skin; one of 4 signatures associated with UV exposure (SBS7a, SBS7c, and SBS7d); also associated with DSB1 and ID13",https://cancer.sanger.ac.uk/signatures/sbs/sbs7b
SBS7c,SBS7c (UV),"Attributed to ultraviolet light (UV) exposure and found in cancers of the skin; one of 4 signatures associated with UV exposure (SBS7a, SBS7b, and SBS7d)",https://cancer.sanger.ac.uk/signatures/sbs/sbs7c
SBS7d,SBS7d (UV),"Attributed to ultraviolet light (UV) exposure and found in cancers of the skin; one of 4 signatures associated with UV exposure (SBS7a, SBS7b, and SBS7c)",https://cancer.sanger.ac.uk/signatures/sbs/sbs7d
SBS8,SBS8 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/sbs/sbs8
SBS9,SBS9 (POL-eta),May be due in part to mutations induced during replication by polymerase eta as part of somatic hypermutation in lymphoid cells; CLLs possessing immunoglobulin gene (IGHV) hypermutation have elevated levels than those without,https://cancer.sanger.ac.uk/signatures/sbs/sbs9
SBS10a,SBS10a (POLE),"Attributed to polymerase epsilon exonuclease domain mutations; usually found in hypermutated samples (>100 per Mb); associated with SBS10b, SBS28 and DSB3",https://cancer.sanger.ac.uk/signatures/sbs/sbs10a
SBS10b,SBS10b (POLE),"Attributed to polymerase epsilon exonuclease domain mutations; usually found in hypermutated samples (>100 per Mb); associated with SBS10b, SBS28 and DSB3",https://cancer.sanger.ac.uk/signatures/sbs/sbs10b
SBS10c,SBS10c (POLD1),Defective POLD1 proofreading; strong lagging replication strand bias; associated with ID1,https://cancer.sanger.ac.uk/signatures/sbs/sbs10c
SBS10d,SBS10d (POLD1),Adenoma from individuals with germline POLD1 exonuclease domain mutations; strong lagging replication strand bias; associated with SBS10c and ID1,https://cancer.sanger.ac.uk/signatures/sbs/sbs10d
SBS11,SBS11 (TMZ),Exhibits a mutational pattern resembling that of alkylating agents and associated with patient histories of temozolomide (TMZ); usually generates large number of mutations (>10 per Mb),https://cancer.sanger.ac.uk/signatures/sbs/sbs11
SBS12,SBS12 (Unknown),Etiology unknown; usually contributes a small percentage (<20%) of mutations in liver cancer,https://cancer.sanger.ac.uk/signatures/sbs/sbs12
SBS13,SBS13 (APOBEC),Attributed to activity of the AID/APOBEC family of cytidine deaminases; usually found with SBS2 and in samples with local hypermutation (kataegis); associated with DSB11,https://cancer.sanger.ac.uk/signatures/sbs/sbs13
SBS14,SBS14 (MMR/MSI),"Associated with concurrent polymerase epsilon mutation, defective DNA mismatch repair (MMR), and microsatellite instability (MSI); present in very high numbers in all samples where it has been observed; one of 7 signatures associated with MMR/MSI (SBS6, SBS15, SBS20, SBS21, SBS26, and SBS44); associated with ID1 and ID2",https://cancer.sanger.ac.uk/signatures/sbs/sbs14
SBS15,SBS15 (MMR/MSI),"Associated with defective DNA mismatch repair (MMR), and microsatellite instability (MSI); one of 7 signatures associated with MMR/MSI (SBS6, SBS14, SBS20, SBS21, SBS26, and SBS44); associated with ID1 and ID2",https://cancer.sanger.ac.uk/signatures/sbs/sbs15
SBS16,SBS16 (Unknown),Unknown etiology; lower levels of nucleotide excision repair and elevated levels of DNA damage on untranscribed strands may contribute,https://cancer.sanger.ac.uk/signatures/sbs/sbs16
SBS17a,SBS17a (Unknown),Unknown etiology; commonly found with SBS17b,https://cancer.sanger.ac.uk/signatures/sbs/sbs17a
SBS17b,SBS17b (Unknown),Unknown etiology but has been linked to fluorouracil (5FU) chemotherapy treatment and reactive oxygen species damage; has similarities to SBS28 and these two signatures can be mistaken for one another; commonly found with SBS17a,https://cancer.sanger.ac.uk/signatures/sbs/sbs17b
SBS18,SBS18 (ROS),Possibly linked to damage by reactive oxygen species (ROS); similar in profile to SBS36 associated with defective base excision repair due to MUTYH mutations,https://cancer.sanger.ac.uk/signatures/sbs/sbs18
SBS19,SBS19 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/sbs/sbs19
SBS20,SBS20 (MMR/MSI),"Associated with concurrent POLD1 mutations and defective DNA mismatch repair (MMR)/microsatellite instability (MSI); one of 7 MMR/MSI signatures: SBS6, SBS14, SBS15, SBS21, SBS26, and SBS44; associated with ID1 and ID2",https://cancer.sanger.ac.uk/signatures/sbs/sbs20
SBS21,SBS21 (MMR/MSI),"DNA mismatch repair (MMR) and microsatellite instability (MSI); one of 7 MMR/MSI signatures: SBS6, SBS14, SBS15, SBS20, SBS26, and SBS44; associated with ID1 and ID2",https://cancer.sanger.ac.uk/signatures/sbs/sbs21
SBS22,SBS22 (Arisolochic acid),Associated with aristolochic acid exposure,https://cancer.sanger.ac.uk/signatures/sbs/sbs22
SBS23,SBS23 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/sbs/sbs23
SBS24,SBS24 (Aflatoxin),Associated with aflatoxin exposure,https://cancer.sanger.ac.uk/signatures/sbs/sbs24
SBS25,SBS25 (Unknown),Unknown etiology but found in some Hodgkin's cell line samples derived from patients exposed to chemotherapy,https://cancer.sanger.ac.uk/signatures/sbs/sbs25
SBS26,SBS26 (MMR/MSI),"One of seven signatures with defective DNA mismatch repair (MMR) and microsatellite instability (MSI); one of 7 MMR/MSI signatures: SBS6, SBS14, SBS15, SBS20, SBS26, and SBS44; associated with ID1 and ID2",https://cancer.sanger.ac.uk/signatures/sbs/sbs26
SBS27,SBS27 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs27
SBS28,SBS28 (Unknown),Unknown etiology; found in most samples with hypermutator signatures SBS10a/SBS10b but contributes much smaller number of mutations,https://cancer.sanger.ac.uk/signatures/sbs/sbs28
SBS29,SBS29 (Tobacco chewing),Associated with tobacco chewing habit,https://cancer.sanger.ac.uk/signatures/sbs/sbs29
SBS30,SBS30 (BER),Attributed to deficiency in base excision repair (BER) due to inactivating mutations in NTHL1,https://cancer.sanger.ac.uk/signatures/sbs/sbs30
SBS31,SBS31 (Platinum),Associated with prior chemotherapy treatment with platinum drugs; exhibits mutation patters similar to SBS35; associated with DSB5,https://cancer.sanger.ac.uk/signatures/sbs/sbs31
SBS32,SBS32 (AZA),Associated with prior treatment with azathioprine (AZA) to induce immunosuppression,https://cancer.sanger.ac.uk/signatures/sbs/sbs32
SBS33,SBS33 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/sbs/sbs33
SBS34,SBS34 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/sbs/sbs34
SBS35,SBS35 (Platinum),Associated with prior chemotherapy treatment with platinum drugs; exhibits mutation patters similar to SBS31; associated with DBS5,https://cancer.sanger.ac.uk/signatures/sbs/sbs35
SBS36,SBS36 (BER),"Associated with defective base excision repair (BER), including DNA damage due to reactive oxygen species and biallelic germline/somatic MUTYH mutations; similar to SBS18",https://cancer.sanger.ac.uk/signatures/sbs/sbs36
SBS37,SBS37 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/sbs/sbs37
SBS38,SBS38 (Unknown),"Unknown etiology; found only in UV-associated melanoma, suggesting indirect damage from UV light",https://cancer.sanger.ac.uk/signatures/sbs/sbs38
SBS39,SBS39 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/sbs/sbs39
SBS40,SBS40 (Unknown),Unknown etiology; number of mutations correlated with patient's age in some types of cancer,https://cancer.sanger.ac.uk/signatures/sbs/sbs40
SBS41,SBS41 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/sbs/sbs41
SBS42,SBS42 (Haloalkane),Associated with occupational exposure to haloalkanes,https://cancer.sanger.ac.uk/signatures/sbs/sbs42
SBS43,SBS43 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs43
SBS44,SBS44 (MMR/MSI),"Associated with defective DNA mismatch repair (MMR) and is found in microsatellite unstable (MSI) tumors; one of 7 signatures associated with MMR/MSI along with SBS6, SBS14, SBS15, SBS20, SBS21, and SBS26; associated ID1 and ID2",https://cancer.sanger.ac.uk/signatures/sbs/sbs44
SBS45,SBS45 (Sequencing),Possible artefact due to 8-oxo-guanine introduced during sequencing,https://cancer.sanger.ac.uk/signatures/sbs/sbs45
SBS46,SBS46 (Sequencing),Possible sequencing artefact; commonly found in colorectal cancers from early releases (prior to 2013) of TCGA,https://cancer.sanger.ac.uk/signatures/sbs/sbs46
SBS47,SBS47 (Sequencing),Possible sequencing artefact; found in cancer samples subsequently blacklisted for poor quality of sequencing data,https://cancer.sanger.ac.uk/signatures/sbs/sbs47
SBS48,SBS48 (Sequencing),Possible sequencing artefact; found in cancer samples subsequently blacklisted for poor quality of sequencing data,https://cancer.sanger.ac.uk/signatures/sbs/sbs48
SBS49,SBS49 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs49
SBS50,SBS50 (Sequencing),Possible sequencing artefact; found in cancer samples subsequently blacklisted for poor quality of sequencing data,https://cancer.sanger.ac.uk/signatures/sbs/sbs50
SBS51,SBS51 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs51
SBS52,SBS52 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs52
SBS53,SBS53 (Sequencing),Possible sequencing artefact; found in cancer samples subsequently blacklisted for poor quality of sequencing data,https://cancer.sanger.ac.uk/signatures/sbs/sbs53
SBS54,SBS54 (Sequencing),Possible sequencing artefact; possible contamination with germline variants,https://cancer.sanger.ac.uk/signatures/sbs/sbs54
SBS55,SBS55 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs55
SBS56,SBS56 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs56
SBS57,SBS57 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs57
SBS58,SBS58 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs58
SBS59,SBS59 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs59
SBS60,SBS60 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs60
SBS84,SBS84 (AID),Attributed to activity of activation-induced cytidine deaminase (AID); found in clustered mutations in immunoglobulin gene and other regions in lymphoid cancers; associated with SBS85,https://cancer.sanger.ac.uk/signatures/sbs/sbs84
SBS85,SBS85 (AID),Attributed to indirect effects of activation-induced cytidine deaminase (AID) induced in somatic mutagenesis in lymphoid cells; found in clustered mutations in immunoglobulin gene and other regions in lymphoid cancers; associated with SBS84,https://cancer.sanger.ac.uk/signatures/sbs/sbs85
SBS86,SBS86 (Unknown),Unknown chemotherapy treatment; found in combination with SBS87 in some relapsed ALL patients,https://cancer.sanger.ac.uk/signatures/sbs/sbs86
SBS87,SBS87 (Thiopurine),"Thiopurine chemotherapy treatment, experimentally validated; found in combination with SBS86 in some relapsed ALL patients; associated with increased CG>NN doublet base substitutions",https://cancer.sanger.ac.uk/signatures/sbs/sbs87
SBS88,SBS88 (Colibactin),"Exposure to E.coli bacteria carrying pks pathogenicity island, producing genotoxic compound colibactin; appears to be most active in the first decade of life; associated with ID18",https://cancer.sanger.ac.uk/signatures/sbs/sbs88
SBS89,SBS89 (Unknown),"Unknown; SBS89 correlates with DBS8, suggesting that they are due to the same underlying mutational process",https://cancer.sanger.ac.uk/signatures/sbs/sbs89
SBS90,SBS90 (Duocarmycin),Duocarmycin exposure,https://cancer.sanger.ac.uk/signatures/sbs/sbs90
SBS91,SBS91 (Unknown),Unknown; enrichment in ALU elements,https://cancer.sanger.ac.uk/signatures/sbs/sbs91
SBS92,SBS92 (Smoking),"Associated with tobacco smoking; found increased in bladder tumours; SBS4, ID3 and DBS2 have also been found associated with tobacco smoking",https://cancer.sanger.ac.uk/signatures/sbs/sbs92
SBS93,SBS93 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/sbs/sbs93
SBS94,SBS94 (Unknown),Unknown etiology,https://cancer.sanger.ac.uk/signatures/sbs/sbs94
SBS95,SBS95 (Sequencing),Possible sequencing artefact,https://cancer.sanger.ac.uk/signatures/sbs/sbs95
Signature_1,Signature 1 (Aging),Correlated with age of cancer diagnosis and found in all cancer types and in most cancer samples ,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_2,Signature 2 (APOBEC),Attributed to activity of AID/APOBEC family of cytidine deaminases; usually found along with Signature 13 and in samples with local hypermutation (kataegis),https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_3,Signature 3 (HRD),"Associated with defetcs in homologous recombination-based DNA repair and BRCA mutations, especially in breast, ovarian, and pancreatic cancers",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_4,Signature 4 (Smoking),"Associated with smoking in lung, head & neck, liver, and esophageal cancers; exhibits strong transcriptional bias for C>A mutations",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_5,Signature 5 (Unknown),Found in all cancer types and most cancer samples; etiology unknown; exhibits transcriptional strand bias for T>C substitutions at ApTpN context,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_6,Signature 6 (MMR),"Associated with defective DNA mismatch repair (MMR) and found in microsatellite (MSI)-unstable tumors; often accompanied by Signatures 15, 20, and 26; most common in colorectal and uterine cancers",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_7,Signature 7 (UV),Associated with ultraviolet light (UV) exposure in skin cancers; exhibits a strong transcriptional strand bias,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_8,Signature 8 (Unknown),Etiology unknown; found in breast cancer and medulloblastoma; shows a weak strand bias for C>A substitions,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_9,Signature 9 (IGHV),Attributed to polymerase eta action and the activity of AID during hypermutation in CLL and B-cell lymphomas; IGHV-mutated CLLs show high Signature 9 compared to those without them,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_10,Signature 10 (POLE),Attributed to altered activity of error-prone polymerase eta (POLE) in ultra-hypermutated samples; strand bias for C>A mutations at TpCpT and T>G at TpTPT,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_11,Signature 11 (TMZ),Signature 11 has been found in melanoma and glioblastoma. Signature 11 exhibits a mutational pattern resembling that of alkylating agents. Patient histories have revealed an association between treatments with the alkylating agent temozolomide and Signature 11 mutations. It exhibits a strong transcriptional strand-bias for C>T substitutions indicating that mutations occur on guanine and that these mutations are effectively repaired by transcription-coupled nucleotide excision repair.,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_12,Signature 12 (Unknown),Signature 12 has been found in liver cancer. The aetiology of Signature 12 remains unknown. It exhibits a strong transcriptional strand-bias for T>C substitutions.,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_13,Signature 13 (APOBEC),"Signature 13 has been found in 22 cancer types and seems to be commonest in cervical and bladder cancers. In most of these 22 cancer types, Signature 13 is present in at least 10% of samples. Signature 13 has been attributed to activity of the AID/APOBEC family of cytidine deaminases converting cytosine to uracil. On the basis of similarities in the sequence context of cytosine mutations caused by APOBEC enzymes in experimental systems, a role for APOBEC1, APOBEC3A and/or APOBEC3B in human cancer appears more likely than for other members of the family. Signature 13 causes predominantly C>G mutations. This may be due to generation of abasic sites after removal of uracil by base excision repair and replication over these abasic sites by REV1.",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_14,Signature 14 (MMR),Signature 14 has been observed in four uterine cancers and a single adult low-grade glioma sample. The aetiology of Signature 14 remains unknown. Signature 14 generates very high numbers of somatic mutations (>200 mutations per MB) in all samples in which it has been observed.,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_15,Signature 15 (MMR),"Signature 15 has been found in several stomach cancers and a single small cell lung carcinoma. Signature 15 is associated with defective DNA mismatch repair. Signature 15 is one of four mutational signatures associated with defective DNA mismatch repair and is often found in the same samples as Signatures 6, 20, and 26.",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_16,Signature 16 (Unknown),"Signature 16 has been found in liver cancer. The aetiology of Signature 16 remains unknown. Signature 16 exhibits an extremely strong transcriptional strand bias for T>C mutations at ApTpN context, with T>C mutations occurring almost exclusively on the transcribed strand.",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_17,Signature 17 (Unknown),"Signature 17 has been found in oesophagus cancer, breast cancer, liver cancer, lung adenocarcinoma, B-cell lymphoma, stomach cancer and melanoma. The aetiology of Signature 17 remains unknown.",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_18,Signature 18 (Unknown),"Signature 18 has been found commonly in neuroblastoma. Additionally, Signature 18 has been also observed in breast and stomach carcinomas.",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_19,Signature 19 (Unknown),Signature 19 has been found only in pilocytic astrocytoma. The aetiology of Signature 19 remains unknown.,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_20,Signature 20 (MMR),"Signature 20 has been found in stomach and breast cancers. Signature 20 is believed to be associated with defective DNA mismatch repair. Signature 20 is one of four mutational signatures associated with defective DNA mismatch repair and is often found in the same samples as Signatures 6, 15, and 26.",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_21,Signature 21 (MMR),"Signature 21 has been found only in stomach cancer. The aetiology of Signature 21 remains unknown. Signature 21 is found only in four samples all generated by the same sequencing centre. The mutational pattern of Signature 21 is somewhat similar to the one of Signature 26. Additionally, Signature 21 is found only in samples that also have Signatures 15 and 20. As such, Signature 21 is probably also related to microsatellite unstable tumours.",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_22,Signature 22 (Aristolochic acid),"Signature 22 has been found in urothelial (renal pelvis) carcinoma and liver cancers. Signature 22 has been found in cancer samples with known exposures to aristolochic acid. Additionally, the pattern of mutations exhibited by the signature is consistent with the one previous observed in experimental systems exposed to aristolochic acid. Signature 22 exhibits a very strong transcriptional strand bias for T>A mutations indicating adenine damage that is being repaired by transcription-coupled nucleotide excision repair. Signature 22 has a very high mutational burden in urothelial carcinoma; however, its mutational burden is much lower in liver cancers.",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_23,Signature 23 (Unknown),Signature 23 has been found only in a single liver cancer sample. The aetiology of Signature 23 remains unknown. Signature 23 exhibits very strong transcriptional strand bias for C>T mutations.,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_24,Signature 24 (Aflatoxin),"Signature 24 has been observed in a subset of liver cancers. Signature 24 has been found in cancer samples with known exposures to aflatoxin. Additionally, the pattern of mutations exhibited by the signature is consistent with that previous observed in experimental systems exposed to aflatoxin. It exhibits a very strong transcriptional strand bias for C>A mutations indicating guanine damage that is being repaired by transcription-coupled nucleotide excision repair.",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_25,Signature 25 (Unknown),Signature 25 has been observed in Hodgkin lymphomas. The aetiology of Signature 25 remains unknown. It exhibits transcriptional strand bias for T>A mutations. This signature has only been identified in Hodgkinâ€™s cell lines. Data is not available from primary Hodgkin lymphomas.,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_26,Signature 26 (MMR),"Signature 26 has been found in breast cancer, cervical cancer, stomach cancer and uterine carcinoma. Signature 26 is believed to be associated with defective DNA mismatch repair. Signature 26 is one of four mutational signatures associated with defective DNA mismatch repair and is often found in the same samples as Signatures 6, 15 and 20.",https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_27,Signature 27 (Unknown),Signature 27 has been observed in a subset of kidney clear cell carcinomas. The aetiology of Signature 27 remains unknown. It exhibits very strong transcriptional strand bias for T>A mutations. Signature 27 is associated with high numbers of small (shorter than 3bp) insertions and deletions at mono/polynucleotide repeats.,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_28,Signature 28 (Unknown),Signature 28 has been observed in a subset of stomach cancers. The aetiology of Signature 28 remains unknown.,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_29,Signature 29 (Tobacco),Signature 29 has been observed only in gingivo-buccal oral squamous cell carcinoma. Signature 29 has been found in cancer samples from individuals with a tobacco chewing habit. Signature 29 exhibits transcriptional strand bias for C>A mutations indicating guanine damage that is most likely repaired by transcription-coupled nucleotide excision repair. Signature 29 is also associated with CC>AA dinucleotide substitutions. The Signature 29 pattern of C>A mutations due to tobacco chewing appears different from the pattern of mutations due to tobacco smoking reflected by Signature 4.,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
Signature_30,Signature 30 (Unknown),Signature 30 has been observed in a small subset of breast cancers. The aetiology of Signature 30 remains unknown.,https://cancer.sanger.ac.uk/cosmic/signatures_v2.tt
